Meeder Asset Management’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-32
| Closed | -$1.11K | – | 918 |
|
|
2025
Q4 | $1.11K | Sell |
32
-2
| -6% | -$157 | ﹤0.01% | 877 |
|
|
2025
Q3 | $2.83K | Buy |
34
+7
| +26% | +$507 | ﹤0.01% | 757 |
|
|
2025
Q2 | $1.98K | Sell |
27
-19
| -41% | -$1.38K | ﹤0.01% | 813 |
|
|
2025
Q1 | $5.25K | Buy |
+46
| New | +$2.8K | ﹤0.01% | 756 |
|
|
2022
Q4 | – | Sell |
-62
| Closed | -$2K | – | 1035 |
|
|
2022
Q3 | $2K | Sell |
62
-26
| -30% | -$696 | ﹤0.01% | 1802 |
|
|
2022
Q2 | $2K | Sell |
88
-40
| -31% | -$871 | ﹤0.01% | 1873 |
|
|
2022
Q1 | $3K | Buy |
+128
| New | +$2.72K | ﹤0.01% | 1928 |
|
|
2021
Q4 | – | Sell |
-47
| Closed | -$1K | – | 1409 |
|
|
2021
Q3 | $1K | Sell |
47
-68
| -59% | -$1.42K | ﹤0.01% | 2296 |
|
|
2021
Q2 | $3K | Buy |
115
+12
| +12% | +$267 | ﹤0.01% | 2086 |
|
|
2021
Q1 | $2K | Buy |
103
+84
| +442% | +$2.24K | ﹤0.01% | 2060 |
|
|
2020
Q4 | $0 | Sell |
19
-9,167
| -100% | -$193K | ﹤0.01% | 1944 |
|
|
2020
Q3 | $159K | Buy |
9,186
+9,171
| +61,140% | +$146K | 0.01% | 661 |
|
|
2020
Q2 | $0 | Buy |
+15
| New | +$211 | ﹤0.01% | 2120 |
|
|
2019
Q1 | – | Sell |
-610
| Closed | -$8K | – | 1725 |
|
|
2018
Q4 | $8K | Buy |
610
+143
| +31% | +$1.89K | ﹤0.01% | 1298 |
|
|
2018
Q3 | $7K | Sell |
467
-996
| -68% | -$13.9K | ﹤0.01% | 1241 |
|
|
2018
Q2 | $23K | Sell |
1,463
-524
| -26% | -$9.12K | ﹤0.01% | 933 |
|
|
2018
Q1 | $33K | Sell |
1,987
-424
| -18% | -$7.86K | ﹤0.01% | 763 |
|
|
2017
Q4 | $43K | Buy |
2,411
+1,525
| +172% | +$27.6K | ﹤0.01% | 726 |
|
|
2017
Q3 | $17K | Buy |
886
+719
| +431% | +$10.7K | ﹤0.01% | 936 |
|
|
2017
Q2 | $2K | Buy |
167
+30
| +22% | +$326 | ﹤0.01% | 1390 |
|
|
2017
Q1 | $2K | Buy |
+137
| New | +$1.2K | ﹤0.01% | 1355 |
|
Other funds holding CORT
ISL
VPM
VCM
PA
